BAY AREA MANUFACTURER AWARDED REGENERATIVE MEDICINE VA SAC CONTRACT
Originally developed for the military to treat field injuries, this regenerative medicine technology has been patented by C. Randall Harrell, MD of Palm Harbor, FL. Dr. Harrell holds two patents for this technology that releases bioengineered proteins using exosomes for regenerative medicine treatments. The subject of exosomes won a Nobel Prize in Medicine in 2013.
Dr. Harrell is the founder, CEO, and Medical Director of Regenerative Processing Plant, LLC (RPP), one of 20 companies sharing in the $2.1Billion VA SAC contract but is the only company with products containing an acellular sterile fluid comprised of 771 proteins that work to stimulate the natural stem cell healing of an injury.
- RegenaMax Exosomes for orthopedic, podiatry, pain management, and soft tissue injuries
- RegenaMax Tissue Allograft for wounds
- iRegen Ophthalmic Solution for dry eyes and other ocular surface diseases
- PurAcel Inhalation Solution for COPD, pulmonary Burn Pit inhalation injuries
The scientific platform technology for these products has been used in over 100,000 treatments with no adverse events reported.
For more information, call Dr. Harrell directly at 727.781.0818
About Regenerative Processing Plant, LLC: RPP is a leading BioPharma company that is a pioneer in the rapidly growing field of Regenerative Medicine. Its visionary CMO is Dr. C. Randall Harrell, who invented and developed patent-protected and proprietary next generation platform technologies and a series of novel biologics for both the commercial market as well as the VA and DoD. These innovative products were designed to meet urgent needs in the fields of pulmonary, burns, wound care, pain, orthopedics, and ophthalmology.